CARDIOFLOW-B (02160) rose 16.2% to HK$1.22, breaking above the 10-D SMA of HK$1.171.
It hits an intra-day high of HK$1.23, and an intra-day low of HK$1.05. The total shares traded was 4.14 million, with a value of HK$4.63m. The active buy/sell ratio is 69:31, with net buying turnover of HK$1.74m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$436,416, with volume weighted average price of HK$1.105. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$438,892, with volume weighted average price of HK$1.145.
| Nominal | 1.220 | % Chg | +16.19% |
| High | 1.230 | Low | 1.050 |
| Shares Tr | 4.14m | Turnover | 4.63m |
| 10-D SMA | 1.171 | %H.V | 52.437 |
| 20-D SMA | 1.222 | VWAP | 1.118 |
| 50-D SMA | 1.275 | RSI14 | 48.883 |
| Stock (Code) | Price (HK$) | Change (%) |
|---|---|---|
| CARDIOFLOW-B (02160) | 1.22 | +16.19 |
| GENSCRIPT BIO (01548) | 14.20 | -1.93 |
| INNOVENT BIO (01801) | 38.25 | -0.78 |
| JXR (01951) | 2.37 | -1.25 |
| EVEREST MED-B (01952) | 22.20 | +3.02 |
| WUXI BIO (02269) | 13.70 | +1.03 |
| WUXI APPTEC (02359) | 37.10 | -2.62 |
| BEIGENE (06160) | 92.25 | -1.49 |
| ZAI LAB (09688) | 12.40 | -1.12 |
| AKESO (09926) | 46.20 | -1.60 |
etnet榮獲HKEX Awards 2023 「最佳表現證券數據供應商」大獎► 了解詳情
